Use of Model‐Based Meta‐Analysis to Inform the Design of Early Clinical Trials of Anti‐Amyloid Beta Therapies in Alzheimer's Disease

ABSTRACT To inform an efficient development of new investigational anti‐amyloid beta (anti‐Aβ) monoclonal antibodies (mAbs), a modeling‐and‐simulation‐based strategy was proposed. A general modeling framework that links drug exposures to the time course of amyloid plaque removal and amyloid‐related...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Sagar S. Bachhav, Ana Victoria Ponce‐Bobadilla, Diana Clausznitzer, Sven Stodtmann, Hao Xiong
Natura: Articolo
Lingua:inglese
Pubblicazione: Wiley 2025-07-01
Serie:CPT: Pharmacometrics & Systems Pharmacology
Soggetti:
Accesso online:https://doi.org/10.1002/psp4.70038
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!